Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Monthly Archives: March 2020
Trust Private Enterprise to Flatten the Curve
Raymond March
-
March 27, 2020
0
FDA Should Expand Options for Coronavirus Patients
Ross Marchand
-
March 26, 2020
0
The Mask Madness of Big Government
K. Lloyd Billingsley
-
March 26, 2020
0
To Battle Covid-19, Cut Regulation!
Raymond March
-
March 25, 2020
0
Favor Local Action to Combat the Coronavirus
Raymond March
-
March 19, 2020
0
FDA Acknowledges Coronavirus Is Causing More Drug Shortages
Raymond March
-
March 6, 2020
0
FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices
Raymond March
-
March 5, 2020
0
